Hangzhou Tigermed Consulting Co Ltd Informations sur les dividendes
Hangzhou Tigermed Consulting Co Ltd a un dividende annuel de 0.7408 par action, avec un rendement de 0.00%. Le dividende est payé annuellement et la dernière date d'ex-dividende était le Jun 12, 2025.
Rendement en dividend
Dividende annuel
Date ex-dividende
0.00%
$0.7408
Jun 12, 2025
Fréquence des paiements
Taux de distribution
Annuellement
0.00%
Historique des dividendes
Date ex-dividende
Montant en espèces
Date de registre
Date de paiement
Jun 12, 2025
$0.3245
Jun 13, 2025
Jul 11, 2025
Jun 7, 2024
$0.6237
Jun 11, 2024
Jul 18, 2024
May 25, 2023
$0.6156
May 29, 2023
Jul 7, 2023
May 24, 2022
$0.5796
May 25, 2022
Jun 20, 2022
Graphiques des dividendes
HTMDF Dividendes
HTMDF Croissance des dividendes (variation annuelle)
Follow-Up Questions
Quel est le dividende actuel payé par Hangzhou Tigermed Consulting Co Ltd et son dividende annuel ?
Quel est le ratio de distribution de dividendes de Hangzhou Tigermed Consulting Co Ltd ?
Quelle est la date ex-dividende pour HTMDF ?
À quelle fréquence Hangzhou Tigermed Consulting Co Ltd verse-t-elle des dividendes ?
Statistiques clés
Clôture préc.
--
Prix d'ouverture
--
Plage de la journée
-
Plage de 52 semaines
-
Volume
--
Volume moyen
--
BPA (TTM)
--
Rendement en dividend
--
Capitalisation boursière
--
Qu’est-ce que HTMDF ?
Hangzhou Tigermed Consulting Co Ltd is a CN-based company operating in Life Sciences Tools & Services industry. The company is headquartered in Hangzhou, Zhejiang and currently employs 10,185 full-time employees. The company went IPO on 2012-08-17. Hangzhou Tigermed Consulting Co Ltd is a China-based holding company engaged in providing clinical trial services for research and development of new drugs. The firm operates two segments. The Clinical Trial Solutions segment provides clinical trial operation services and medical translation services to biopharmaceutical and medical device companies and thus help them conduct clinical trials of innovative drugs, generic drugs and medical devices. The Clinical-Related and Laboratory Services segment is involved in provision of analytical services, such as data management and statistical analysis; logistics and execution support services, such as clinical trial site management; administrative assistance, such as patient recruitment; as well as consulting services. This segment also provides laboratory services for preclinical and clinical development stages through its subsidiary. The firm conducts its businesses in the domestic and overseas markets.